Antisense oligodeoxynucleotides are a promising new class of antiviral agent. Because they bind in a sequence-specific manner to complementary regions of mRNA, oligos can inhibit gene expression in a sequence-specific manner. The ‘antisense’ approach has been used successfully to block cellular expression and replication of several viruses including Human Immunodeficiency Virus-1 (HIV-1), and Herpes Simplex Virus (HSV). However, the antiviral effect of oligodeoxynucleotides is not limited to sequence-specific inhibition of gene expression. Non sequence-specific effects are frequently observed, presumably as a result of their properties as polyanions. Occasionally (e.g. for HIV-1) these non sequence-specific effects are also therapeutic. The prospects for antisense oligodeoxynucleotide therapy for viral disease are discussed.
References
1.
AgrawalS.GoodchildJ.CiveiraM.P.ThorntonA.H.SarinP.S., and ZamecnikP.C. (1988) Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus. Proc Natl Acad Sci, USA85: 7079–7083.
2.
AgrawalS.ikeuchiT.SunD.SarinP.S.KonokaA.MaizelJ., and ZamecnikP.C. (1989) Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues. Proc Natl Acad Sci, USA86: 7790–7794.
3.
AgrawalS.TemsamaniJ., and TangJ.Y. (1991) Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc Natl Acad Sci, USA88: 7595–7599.
4.
AgrisC.H.BlakeK.P.MillerP.S.ReddyM.P., and Ts'oP.O. (1986) Inhibition of vesicular stomatitis virus protein synthesis and infection by sequence-specific oligodeoxyribonucleoside methylphosphonates. Biochemistry25: 6268–6275.
5.
BirgF.PraseuthD.ZerialA.ThuongN.T.AsselineU.le DoanT., and HeleneC. (1990) Inhibition of simian virus 40 DNA replication in CV-1 cells by an oligodeoxynucleotide covalently linked to an intercalating agent. Nucleic Acids Res18: 2901–2908.
6.
BoutourinA.Gus'kovaE.IvonovaE.M.KobetzN.D.ZarytovaV.F.RyteA.S.YurchenkoL.V., and VlassovV.V. (1989) Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenzinium residues at their 3′ terminus and their interaction with DNA within mammalian cells. FEBS Lett254: 129–132.
7.
ChengY., and PrusoffW. (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (l50) of an enzymatic reaction. Biochem Pharmacol22: 3099–3108.
8.
ChinD.J. (1992) Inhibition of human immunodeficiency virus type 1 Rev-Rev-response element complex formation by complementary oligonucleotides. J Virol66: 600–607.
9.
ChouT.C.ZhuQ.Y., and SteinC.A. (1991) Differential alteration of the anti-HIV-1 effect of phosphorothioate oligonucleotide S-dC28 by AZT, Interferon-Alpha, and Dextran sulfate. AIDS Res Hum Retroviruses7: 943–951.
10.
CitroG.PerrotiD.CuccoC.D'AgnanoJ.SacchiA.ZupiG., and CalabrettaB. (1992) Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci, USAB9: 7031–7035.
11.
DaumT.EngelsJ.W.MagM.MuthJ.LukingS.SchroderH.C.MatthesE., and MullerW.E.G. (1992) Antisense oligodeoxynucleotide: Inhibitor of splicing of mRNA of human immunodeficiency virus. Intervirology33: 65–75.
12.
DegolsG.LeonettiJ.P.GagnorC.LemaitreM., and LebleuB. (1989) Antiviral activity and possible mechanisms of action of oligonucleotides-poly(L-lysine) conjugates targeted to vesicular stomatitis virus mRNA and genomic RNA. Nucleic Acids Res17: 9341–9350.
13.
DraperK.G.CeruzziM.KmetzM.E., and SturzenbeckerL.J. (1990) Complementary oligonucleotide sequence inhibits both Vmw65 gene expression and replication of herpes simplex virus. Antiviral Res13: 151–164.
14.
FieldsA.P.BednarikD.P.HessA., and MayS. (1988) Human immunodeficiency virus induces phosphorylation of its cell surface receptor. Nature333: 278–280.
15.
GaoW.SteinC.A.CohenJ.S.DutschmanG.E., and ChengY. (1989) Effect of phosphorothioate homo-oligodeoxynucleo-tides on Herpes Simplex Virus type 2-induced DNA polymerase. J Biol Chem264: 11521–11526.
16.
GaoW.HanesR.N.Vazquez-PaduaM.A.SteinC.A.CohenJ.S., and ChengY. (1990) Inhibition of Herpes Simplex Virus type 2 growth by phosphorothioate oligodeoxynucleotides. Antimicrob Agents Chemother34: 808–812.
17.
GaoW.HanF.StormC.EganW., and ChengY. (1992) Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: Implications of antisense technology. Mol Pharmacol41: 223–229.
18.
GoodarziG.GrossS.C.TewariA., and WatabeK. (1990) Antisense oligodeoxyribonucleotides inhibit the expression of the gene for hepatitis B virus surface antigen. J Gen Virol71: 3021–3025.
19.
IversenP. (1991) In vivo studies with phosphorothioate oligonucleotides: pharmacokinetics prologue. Anti-Cancer Drug Des6: 531–538.
20.
KabanovA.V.VinogradovS.V.OvcharenkoA.V.KrivonosA. V.Melik-NubarovN.S.KiselevV.I., and SeverinE.S. (1990) A new class of antivirals: antisense oligonucleotides combined with a hydrophobic substituent effectively inhibit influenza virus reproduction and synthesis of virus-specific proteins in MDCK cells. FEBS Lett259: 327–330.
21.
KriegA.M.TonkinsonJ.MatsonS.ZhaoQ.SaxonM.ZhangL.M.BhanjaU.YakubovL., and SteinC.A. (1993) Modification of antisense phosphodiester oligodeoxynucleotides by a 5′ cholesteryl moiety increases cellular association and improves efficacy. Proc Natl Acid Sci, USA90: 1048–1052.
22.
KulkaM.SmithC.C.AurelianL.FishelevichR.MeadeK.MillerP., and Ts'oP.O.P. (1989) Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonatejs complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4. Proc Natl Acad Sci, USA86: 6868–6972.
23.
LaurenceJ.SikderA.K.KulkoslyJ.MillerP., and Ts'oP.O.P. (1991) Induction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer element. J Virol65: 213–219.
24.
LedermanS.BergmannJ.ClearyA.YellinM.FuscoP., and ChessL. (1992) Sulfated polyester interactions with the CD4 molecule and with the third variable loop domain (v3) of gp120 are chemically distinct. AIDS Res Hum Retrovir8: 1613–1624.
LetsingerR.L.ZhangG.SunD.K.IkeuchiT., and SarinP. (1989) Cholesteryl-conjugated oligonucleotides: Synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture. Proc Natl Acad Sci, USA86: 6553–6556.
27.
LokeS.SteinC.A.ZhangX.H.MoriK.NakanishiM.SubasingheC.CohenJ.S., and NeckersL.M. (1989) Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci, USA86: 3474–3478.
28.
McShanW.M.RossenR.D.LaughterA.H.TrialJ.KesslerD.J.ZendeguJ.G.HoganM.E., and OrsonF.M. (1992) Inhibition of transcription of HIV-1 in infected human cells by oligodeoxynucleotides designed to form DNA triple helices. J Biol Chem267: 5712–5721.
29.
MajumdarC.SteinC.A.CohenJ.S.BroderS., and WilsonS.H. (1989) Stepwise mechanism of HIV reverse transcriptase: Primer function of phosphorothioate oligodeoxynucleotide. Biochemistry28: 1340–1346.
30.
MarshallW.S.BeatonG.SteinC.A.MatsukuraM., and CaruthersM. (1992) Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine. Proc Natl Acad Sci, USA89: 6264–6269.
31.
MatsukuraM.ShinozukaK.ZonG.MitsuyaH.ReitzM.CohenJ.S., and BroderS. (1987) Phosphorothioate analogs of oligodeoxynucleotides: Inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc Natl Acad Sci, USA84: 7706–7710.
32.
MatsukuraM.ZonG.ShinozukaK.Robert-GuroffM.ShimadaT.SteinC.A.MitsuyaH.Wong-StaalF.CohenJ.S., and BroderS. (1989) Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells. Proc Natl Acad Sci, USA86: 4244–4248.
33.
SarinP.S.AgrawalS.CiveiraM.P.GoodchildJ.IkeuchiT., and ZamecnikP.C. (1988) Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates. Proc Natl Acad Sci, USA85: 7448–7451.
34.
ScholsD.PauwelsR.DesmyterJ., and DeClercqE. (1990) Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. Virology175: 556–561.
35.
SheaR.G.MarstersJ.C., and BischofbergerN. (1990) Synthesis, hybridization properties and antiviral activity of lipid-oligodeoxynucleotide conjugates. Nucleic Acids Res18: 3777–3783.
36.
ShojiY.AkhtarS.PeriasamyA.HermanB., and JulianoR.L. (1991) Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages. Nucleic Acids Res19: 5543–5550.
37.
SteinC.A.SubasingheC.ShinozukaK., and CohenJ.S. (1988) Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res16: 3209–3221.
38.
SteinC.A.MatsukuraM.SubasingheC.BroderS., and CohenJ.S. (1989) Phosphorothioate oligodeoxynucleotides are potent sequence nonspecific inhibitors of de novo infection by HIV. Aids Res Hum Retrovir5: 639–646.
39.
SteinC.A.NeckersL.M.NairB.C.MumbauerS.HokeG., and PalR. (1991) Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4. J AIDS4: 686–693.
40.
SteinC.A.PalR.DeVicoA.L.HokeG.MumbauerS.KinstlerO.SarngadharanM.G., and LetsingerR.L. (1991) Mode of action of 5′-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro. Biochemistry30: 2439–2444.
41.
SteinC.A.TonkinsonJ.L., and YakubovL. (1991) Phosphorothioate oligodeoxynucleotides – anti-sense inhibitors of gene expression?Pharm Ther52: 365–384.
42.
SteinC.A. (1992) Anti-sense oligodeoxynucleotides – Promises and pitfalls. Leukemia6: 967–974.
43.
SteinC.A.ClearyA.M.YakubovL., and LedermanS. (1993) Phosphorothioate oligodeoxynucleotides bind to the third variable loop domain (v3) of HIV-1 gp120. Antisense Res and Dev, in press.
44.
SteinC.A.TonkinsonJ.L.ZhangL.M.YakubovL.GervasoniJ.TaubR., and RotenbergS.A. (1993) Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells. Biochemistry, in press.
45.
VickersT.BakerB.F.CookP.D.ZounesM.BuckheitR.W.GermanyJ., and EckerD.J. (1991) Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element. Nucleic Acids Res19: 3359–3368.
46.
YakubovL.A.DeevaE.A.ZarytovaV.F.IvanovaE.M.RyteA.S.YurchenkoL.V., and VlassovV.V. (1989) Mechanism of oligonucleotide uptake by cells: Involvement of specific receptors?Proc Natl Acad Sci, USA86: 6454–6458.
47.
ZamecnikP., and StephensonM. (1978) Inhibition of rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci, USA75: 280–284.
